The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ferrograd C 325mg/500mg Prolonged release Tablets

Teofarma S.R.L.PA1235/002/001

Main Information

Trade NameFerrograd C 325mg/500mg Prolonged release Tablets
Active SubstancesFerrous sulfate
Sodium ascorbate
Dosage FormProlonged-release tablet
Licence HolderTeofarma S.R.L.
Licence NumberPA1235/002/001

Group Information

ATC CodeB03AA Iron bivalent, oral preparations
B03AA07 ferrous sulfate


License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back